Complete Text of Report is available in PDF format (1.79 mb). Copies can also be obtained by contacting the Office of Public Affairs at 202-619-1343.
In a follow-up audit of Minnesota’s Medicaid drug rebate
program, we found that, as of June 30, 2006, the State had
established controls for collecting rebates on
single-source drugs administered by physicians. Manufacturers may make
their outpatient drugs eligible for Federal Medicaid funding by entering into a
rebate agreement with CMS and paying quarterly rebates to the States.
Because the State had adequate controls over its drug rebate program, we made no recommendations.